Gallstone disease cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
| Line 10: | Line 10: | ||
===Laparscopic cholecystectomy=== | ===Laparscopic cholecystectomy=== | ||
It is considered cost effective since laparscopic cholecystectomy removes gallstones 99% of the time and avoids the need for prolonged hospital stays, recovery time, medical costs and future intervention.<ref name="pmid8054014">{{cite journal |vauthors=Darzi A, Geraghty JG, Williams NN, Sheehan SS, Tanner AN, Keane FB |title=The pros and cons of laparoscopic cholecystectomy and extracorporeal shock wave lithotripsy in the management of gallstone disease |journal=Ann R Coll Surg Engl |volume=76 |issue=1 |pages=42–6 |year=1994 |pmid=8054014 |pmc=2502162 |doi= |url=}}</ref> | *It is considered cost effective since laparscopic cholecystectomy removes gallstones 99% of the time and avoids the need for prolonged hospital stays, recovery time, medical costs and future intervention.<ref name="pmid8054014">{{cite journal |vauthors=Darzi A, Geraghty JG, Williams NN, Sheehan SS, Tanner AN, Keane FB |title=The pros and cons of laparoscopic cholecystectomy and extracorporeal shock wave lithotripsy in the management of gallstone disease |journal=Ann R Coll Surg Engl |volume=76 |issue=1 |pages=42–6 |year=1994 |pmid=8054014 |pmc=2502162 |doi= |url=}}</ref> | ||
<ref name="pmid9200309">{{cite journal |vauthors=Portincasa P, van de Meeberg P, van Erpecum KJ, Palasciano G, VanBerge-Henegouwen GP |title=An update on the pathogenesis and treatment of cholesterol gallstones |journal=Scand. J. Gastroenterol. Suppl. |volume=223 |issue= |pages=60–9 |year=1997 |pmid=9200309 |doi= |url=}}</ref> | <ref name="pmid9200309">{{cite journal |vauthors=Portincasa P, van de Meeberg P, van Erpecum KJ, Palasciano G, VanBerge-Henegouwen GP |title=An update on the pathogenesis and treatment of cholesterol gallstones |journal=Scand. J. Gastroenterol. Suppl. |volume=223 |issue= |pages=60–9 |year=1997 |pmid=9200309 |doi= |url=}}</ref> | ||
===Medical dissolution therapy=== | ===Medical dissolution therapy=== | ||
The course of therapy is often long and it can take months, and up to years to completely dissolve stones. Therefore, this treatment is considered to be expensive. | *The course of therapy is often long and it can take months, and up to years to completely dissolve stones. Therefore, this treatment is considered to be expensive. | ||
==References== | ==References== | ||
Revision as of 17:47, 8 December 2017
|
Gallstone disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Surgery |
|
Case Studies |
|
Gallstone disease cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Gallstone disease cost-effectiveness of therapy |
|
Risk calculators and risk factors for Gallstone disease cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]
Overview
Laparoscopic cholecystectomy is considered the most cost effective treatment since it prevents recurrence and complications from happening in the future. On the other hand, medical dissolution therapy needs time to work effectively and therefore is considered costly.
Cost-effectiveness of Therapy
Laparscopic cholecystectomy
- It is considered cost effective since laparscopic cholecystectomy removes gallstones 99% of the time and avoids the need for prolonged hospital stays, recovery time, medical costs and future intervention.[1]
Medical dissolution therapy
- The course of therapy is often long and it can take months, and up to years to completely dissolve stones. Therefore, this treatment is considered to be expensive.
References
- ↑ Darzi A, Geraghty JG, Williams NN, Sheehan SS, Tanner AN, Keane FB (1994). "The pros and cons of laparoscopic cholecystectomy and extracorporeal shock wave lithotripsy in the management of gallstone disease". Ann R Coll Surg Engl. 76 (1): 42–6. PMC 2502162. PMID 8054014.
- ↑ Portincasa P, van de Meeberg P, van Erpecum KJ, Palasciano G, VanBerge-Henegouwen GP (1997). "An update on the pathogenesis and treatment of cholesterol gallstones". Scand. J. Gastroenterol. Suppl. 223: 60–9. PMID 9200309.